Psychedelics are psychoactive substances that trigger unusual mental states, also referred to as "trips," altering the ...
Neumora Therapeutics (NMRA) has been able to establish an advanced phase 3 program, which is ultimately going to be composed of several late-stage studies. This is going to be the inclusion of three ...
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet ...
The largest and most ethnically diverse study of its kind has identified 697 genetic variants linked to major depressive disorder (MDD). The research also highlights potential therapies for ...
Major depressive disorder (MDD) not only takes a toll on your mental health, but can also put a strain on your finances. The cost of treating depression in the United States topped $320 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results